BioLight enters into agreement to distribute ophthalmology laser in Asia

BioLight Life Sciences Investments (Tel Aviv, Israel), a firm that invests in, manages, and commercializes ophthalmology and cancer diagnostics innovations, has signed an exclusive distribution agreement for sales and marketing of IOPtima's (also in Tel Aviv) IOPtiMate ophthalmology laser system in Hong Kong and Macao. The initial term of the agreement includes the purchase of at least nine systems.

Related: IOptima receives European patent approval for laser system for treatment of glaucoma

The system, based on CO2 laser technology, enables a unique filtration surgery to treat glaucoma without penetrating the inner part of the eyeball, allowing for substantial reductions in post-operative complications and use of eye drops compared with alternatives.

A medical center in Hong Kong recently purchased the system, while an additional system has been installed on a trial basis at a second Hong Kong-based medical center.

The company began marketing to physicians and medical centers in China after receiving approval in March 2014 from the China Food and Drug Administration (CFDA) to market and sell the system.

(Thumbnail image via Shutterstock)

-----

Follow us on Twitter, 'like' us on Facebook, connect with us on Google+, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Lightweight handheld probe for OCT provides insight into children's retinas

A handheld device is capable of capturing OCT images of a retina with cellular resolution in infants and toddlers.

NeuroVision receives $10M in financing for optical imaging device to detect Alzheimer's

NeuroVision Imaging has raised Series B financing for its optical imaging device to detect and monitor Alzheimer's disease early.  

Optical elastography method targets corneal disease, with implications for other eye diseases

Optical elastography could lead to more effective therapies for degenerative corneal disease and other eye diseases.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World